Manjiri Ranade*, Prakash Deshmukh, Sweety Purushottham and Prasad Kasliwal
Interventional Pain Physician, Palash Pain and Palliative Care, India
*Corresponding Author: Manjiri Ranade, Interventional Pain Physician, Palash Pain and Palliative Care, India.
Received: December 16, 2020; Published: January 28, 2021
Since the end of 2019, the whole world has been suffering through the pandemic of the new Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Pain is a most common symptom during Novel Coronavirus Disease 2019 (COVID-19). According to the World Health Organization, patients suffering from COVID-19 show symptoms of muscle pain (myalgia) and/or joint pain (arthralgia), sore throat and headache. We present a narrative review of musculoskeletal manifestation and available treatment options. Our aim is to update the pain physicians and physicians working with COVID-19 Patients about possible pathogenesis of myalgia and best proposed treatment available.
Research data for this article is based on literature search which has been referenced in the text. There was no preliminary data. A search of PubMed and Google Scholar was done. We found 15 scientific papers on the related topics. Based on the review we infer that in addition to the cytokine storm experienced by many COVID-19 patients, certain additional factors such as severity of COVID-19 infection contributes to post covid myalgia and fatigue.
Keywords: Coronavirus; Neuropathy; Myalgia; Arthralgia; Headache; Opioids
Citation: Manjiri Ranade., et al. “Systematic Review of Post Covid Myalgia Literature".Acta Scientific Orthopaedics 4.2 (2021): 73-77.
Copyright: © 2021 Manjiri Ranade., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.